LCM
MIRM icon

Legato Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Legato Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85M Buy
58,512
+16,749
+40% +$1.68M 0.57% 23
2026
Q1 		$3.86M Sell
41,763
-2,361
-5% -$222K 0.35% 62
2025
Q4 		$3.49M Buy
44,124
+9,557
+28% +$686K 0.3% 62
2025
Q3 		$2.53M Buy
34,567
+2,804
+9% +$178K 0.28% 99
2025
Q2 		$1.62M Buy
31,763
+15,211
+92% +$677K 0.19% 154
2025
Q1 		$746K Buy
16,552
+3,157
+24% +$149K 0.1% 330
2024
Q4 		$554K Buy
13,395
+977
+8% +$40.7K 0.07% 426
2024
Q3 		$484K Buy
+12,418
New +$495K 0.06% 448
2024
Q2 		– Sell
-12,153
Closed -$305K – 609
2024
Q1 		$305K Sell
12,153
-27,654
-69% -$760K 0.04% 508
2023
Q4 		$1.18M Buy
39,807
+3,490
+10% +$106K 0.15% 223
2023
Q3 		$1.15M Buy
36,317
+10,320
+40% +$283K 0.17% 206
2023
Q2 		$673K Buy
+25,997
New +$691K 0.09% 350

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legato Capital Management's MIRM Position: Q2 2026 in Review

Legato Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 40% in Q2 2026, buying an estimated $1.68M and bringing the position to 58,512 shares worth $6.85M. The position accounts for 0.57% of the portfolio, ranked #23.

Legato Capital Management first reported a position in MIRM in Q2 2023 and has held it in 12 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Legato Capital Management held 58,512 shares of Mirum Pharmaceuticals worth $6.85M as of Q2 2026.
  • Legato Capital Management bought 16,749 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.68M.
  • Mirum Pharmaceuticals made up 0.57% of Legato Capital Management's portfolio in Q2 2026, its #23 holding.
  • Legato Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.